Demographics (2)
- age_enroll - Enrollment age (year) of participant (phv00367488.v1.p1)
- gender - Gender of participant (phv00367489.v1.p1)
Other (16)
- CONSENT - Consent group as determined by DAC (phv00367482.v1.p1)
- SAMPLE_ID - De-identified Sample ID (phv00367490.v1.p1)
- SAMPLE_ID - Sample ID (phv00367483.v1.p1)
- SAMPLE_ID - De-identified Sample ID (phv00367671.v1.p1)
- sample_name_16s - Sample name used in 16S rRNA seq analysis (phv00367492.v1.p1)
- sample_name_rnaseq - Sample name used in RNAseq analysis (phv00367491.v1.p1)
- Seq_RNA - Whole transcriptome sequencing data available (phv00367496.v1.p1)
- Seq_rRNA_16S - 16S rRNA sequencing data available (phv00367497.v1.p1)
- SRA_accession - SRA submission numbers (phv00367672.v1.p1)
- study_timept - Sample collection time point (phv00367495.v1.p1)
- subject - Blinded Subject ID (phv00367487.v1.p1)
- SUBJECT_ID - De-identified Subject ID (phv00367486.v1.p1)
- SUBJECT_ID - Subject ID (phv00367481.v1.p1)
- SUBJECT_ID - Subject ID (phv00367484.v1.p1)
- symptom - Clinical symptom after challenge (phv00367494.v1.p1)
- vaccine - Vaccine received (phv00367493.v1.p1)